Solid Biosciences Inc.
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophi…
Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Solid Biosciences Inc. (SLDB) to it's peer group.
Peer Group
RVMD CGEM CABA PASG ALEC PMVP CCCC BDTX LRMR MLYS EWTX GLUE ANEB TCRR IPSC ACRV STOK BCEL
Compare Together
Loading...